Search Results

<< Back to podcast list Strategic Partner(s) Brian Shoichet About Dr. Brian Shoichet BSc in Chemistry from MIT, Ph.D. with Tack Kuntz at UCSF; Postdoc with Brian Matthews crystallography; started my independent lab at Northwestern University Medical School (1996) was recruited back

. << Back to podcast list Strategic Partner(s) Hacking GPCRs: Tools, Tech & Drug Discovery with Tom Sakmar In Ilana’s words, it’s a powerful way to “go from many back to one.”

<< Back to podcast list Strategic Partner(s) Dr. Katarina Nemec About Dr. to combine experimental approaches with data-driven discovery and adopt data science methodology to tackle

<< Back to podcast list Strategic Partner(s) Dr. Bianca Plouffe About Dr. Bianca Plouffe Dr. of Bouvier’s team, Bianca used Bioluminescence Resonance Energy Transfer (BRET)-based technology to tackle

<< Back to podcast list Strategic Partner(s) Dr. Simone Prömel & Dr. Ines Liebscher About Dr. With the little knowledge on these receptors available, there were multiple questions to tackle.

. < Back to Webinars 📅 Thursday, June 25, 2026 at 3:00:00 PM UTC Register Here 🤝 Webinar in collaboration A reagent gap that holds back the biology GPCR activity is targeted by one-third of all FDA-approved GeneTex is tackling that problem with a high-throughput recombinant antibody platform paired with enhanced

Terry Kenakin < Back Workshop Summary Join Dr. avoiding unwanted side effects. 🗣️ Interactive Q&A : The discussion wraps up with an insightful Q&A, tackling The talk explores how to navigate this crucial gap. 📌 The Future of Drug Development 🚀 🔹 By integrating Whether you're a researcher, student, or industry professional, this session is packed with insights

<< Back to podcast list Strategic Partner(s) Dr. Demet Araç About Dr. He explained that initially, the field lacked adequate tools, and his lab had to develop new techniques Demet shared his belief that he was driven by a biological need to tackle more challenging tasks.

Strategic Partners Back to Partners List Submit Thanks for submitting! We'll get back to you to set up a meeting.

<< Back to podcast list Strategic Partner(s) Dr. Claudia Stäubert About Dr. Yamina expressed interest in learning more about this topic as she realized her lack of knowledge on topic, with Claudia concluding that diseases might first affect the metabolites and not necessarily lack

. << Back to podcast list Strategic Partner(s) Aaron Sato: Synthetic Antibody Libraries for the Hardest Phage display's ~10¹⁰ variant ceiling can be broken by stacking libraries. Aaron has a proven track record as a biologics leader as he led teams to discover and develop novel first-in-class Twist Bioscience’s proprietary technology to manufacture DNA at a scale, the team saw an opportunity to tackle

. << Back to podcast list Strategic Partner(s) From Curiosity to Breakthrough: Ajay Yekkirala on GPCR Originally on track to pursue an MD/PhD, a rejection letter pivoted him into a PhD program at the University Driven by the opioid crisis and the lack of non-addictive pain treatments, Ajay co-founded Blue Therapeutics

. << Back to podcast list Strategic Partner(s) Xylazine, Fentanyl, and the Fight for Breath with Catherine different mechanisms—work that blends receptor pharmacology, preclinical models, and public health data to tackle

. << Back to podcast list Strategic Partner(s) Graciela Pineyro: Resilience, Lab Life, and the Zoom Effect She talks about finally being able to ask which projects deserved to be finished first, second, third We have to go back now and start from scratch." "Zoom democratizes the world. So if we are sent back home, at least we have something to work on." and forth for a while before everything goes back to normal."

<< Back to podcast list Strategic Partner(s) Dr. Michael Feigin About Dr. Michael Feigin "Dr. Mike also spoke about his initial struggles during his Ph.D., such as a difficult model system and a lack Mike expressed his initial reluctance due to a lack of confidence and fear of not being ready. Mike reflected on his early years as a postdoc, admitting that he lacked focus and didn't see the direct

. << Back to podcast list Strategic Partner(s) Yamina Berchiche: Beyond the Lab — From Chemokine Receptors newsletters, summits, and working spaces designed to give the field connective tissue it has historically lacked The lab had no equipment, only stacks of bills on every bench — and a research program on chemokines were generated using AI for readability. 00:00 Introduction 02:25 The closet studio and what's in the talk I gave a talk on October 12th at the 3rd ERNEST meeting about the Dr.GPCR Ecosystem .

And if you stay, your trial fee comes back as a credit. $49 14-days of full Premium access Credited toward Nothing held back. The Math Your trial fee is never lost The $49 comes back as a credit. Either way, you win. Nothing is held back. You get everything Premium members have for 14 days. Can I start anytime? And if you stay, it comes back as a credit toward your first year.

< Back to Vault Title I'm a paragraph. I'm connected to your collection through a dataset.

< Back to Vault Title I'm a paragraph. I'm connected to your collection through a dataset.

< Back to Vault Title I'm a paragraph. I'm connected to your collection through a dataset.

<< Back to podcast list Strategic Partner(s) Dr. Hannes Schihada About Dr. By the end of 2021, I moved back to Germany and joined the pharmaceutical chemistry group of Peter Kolb

. << Back to podcast list Strategic Partner(s) Custom Molecules, Fluorescent Probes: When Chemists Think expand its visibility and impact—offering its expertise, tools, and real-world insight to researchers tackling

. << Back to podcast list Strategic Partner(s) Charlotte Crauwels: Designing Hybrid GPCRs with Computational families in pharmacology and drug discovery, yet many receptors remain poorly characterized or “orphan,” lacking Looking back, my path to this work was not very linear. Yamina Berchiche: Looking back at your PhD trajectory, what originally drew you to computational research Yamina Berchiche: Let’s talk about your PhD project. What was the core idea behind your research?

<< Back to podcast list Strategic Partner(s) Dr. Kaavya Krishna Kumar About Dr.

<< Back to podcast list Strategic Partner(s) Dr. Evi Kostenis About Dr.

<< Back to podcast list Strategic Partner(s) You never know where your GPCR takes you with Dr.

<< Back to podcast list Strategic Partner(s) Yao Lu (Jackie) About Yao Lu (Jackie) "Jackie is a Ph.D.

<< Back to podcast list Strategic Partner(s) Dr. Matthew Eddy About Dr.

<< Back to podcast list Strategic Partner(s) Mark Schmeizl About Mark Schmeizl Mark leverages 30 years

<< Back to podcast list Strategic Partner(s) Robert Laprairie About Dr. Robert Laprairie Dr.